Chishala Chabala

1.3k total citations
31 papers, 436 citations indexed

About

Chishala Chabala is a scholar working on Infectious Diseases, Pediatrics, Perinatology and Child Health and Epidemiology. According to data from OpenAlex, Chishala Chabala has authored 31 papers receiving a total of 436 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Infectious Diseases, 10 papers in Pediatrics, Perinatology and Child Health and 10 papers in Epidemiology. Recurrent topics in Chishala Chabala's work include Tuberculosis Research and Epidemiology (10 papers), HIV/AIDS drug development and treatment (10 papers) and Child Nutrition and Water Access (5 papers). Chishala Chabala is often cited by papers focused on Tuberculosis Research and Epidemiology (10 papers), HIV/AIDS drug development and treatment (10 papers) and Child Nutrition and Water Access (5 papers). Chishala Chabala collaborates with scholars based in Zambia, United Kingdom and Uganda. Chishala Chabala's co-authors include Alimuddin Zumla, Lophina Chilukutu, John Tembo, Matthew Bates, Peter Mwaba, Nathan Kapata, Mwila Kabwe, Diana M. Gibb, Andrea Rachow and Michael Höelscher and has published in prestigious journals such as Clinical Infectious Diseases, PLoS Medicine and The Lancet Infectious Diseases.

In The Last Decade

Chishala Chabala

29 papers receiving 430 citations

Peers

Countries citing papers authored by Chishala Chabala

Since Specialization

Citations

This map shows the geographic impact of Chishala Chabala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chishala Chabala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chishala Chabala more than expected).

Fields of papers citing papers by Chishala Chabala

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chishala Chabala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chishala Chabala. The network helps show where Chishala Chabala may publish in the future.

Co-authorship network of co-authors of Chishala Chabala

This figure shows the co-authorship network connecting the top 25 collaborators of Chishala Chabala. A scholar is included among the top collaborators of Chishala Chabala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chishala Chabala. Chishala Chabala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Centrifuge-free stool processing methods for Xpert MTB/RIF Ultra tuberculosis diagnosis in children in Uganda and Zambia: an observational, prospective, diagnostic accuracy study 2025 ·The Lancet Microbe ·Manon Lounnas, (unknown), (unknown), (unknown), (unknown), Pamela Nabeta, Morten Rühwald, Petra de Haas, Edine Tiemersma, (unknown), Mark P. Nicol, Sara Eyangoh, Eric Wobudeya, Juliet Mwanga‐Amumpaire, Chishala Chabala, Olivier Marcy, Maryline Bonnet, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1
2	Treatment decision algorithms for tuberculosis screening and diagnosis in children below 5 years hospitalised with severe acute malnutrition: a cost-effectiveness analysis 2025 ·EClinicalMedicine ·Marc d’Elbée, Nyashadzaishe Mafirakureva, Chishala Chabala, (unknown), Martin Harker, Clémentine Roucher, (unknown), (unknown), (unknown), Veronica Mulenga, Maryline Bonnet, Eric Wobudeya, Olivier Marcy, Peter J. Dodd	0
3	Pharmacokinetics of once-daily darunavir/ritonavir in second-line treatment in African children with HIV 2024 ·Journal of Antimicrobial Chemotherapy ·(unknown), (unknown), Hylke Waalewijn, Alexander J. Szubert, Veronica Mulenga, Chishala Chabala, Mutsa Bwakura‐Dangarembizi, (unknown), (unknown), Victor Musiime, (unknown), (unknown), (unknown), Helen McIlleron, (unknown), Diana M. Gibb, Paolo Denti, Roeland E. Wasmann, Angela Colbers	2
4	Development of tuberculosis treatment decision algorithms in children below 5 years hospitalised with severe acute malnutrition in Zambia and Uganda: a prospective diagnostic cohort study 2024 ·EClinicalMedicine ·Chishala Chabala, Clémentine Roucher, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Veronica Mulenga, Hamish Graham, Eric Wobudeya, Maryline Bonnet, Olivier Marcy, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	4
5	Management of the infant born to a mother with tuberculosis: a systematic review and consensus practice guideline 2024 ·The Lancet Child & Adolescent Health ·(unknown), Clare Nourse, H. Simon Schaaf, Adrie Bekker, Marian Loveday, (unknown), Christopher Coulter, Chishala Chabala, S. K. Kabra, (unknown), Elizabeth Maleche‐Obimbo, Nicole Salazar‐Austin, Nicole Ritz, Jeffrey R. Starke, Andrew P. Steenhoff, Rina Triasih, Steven Welch, Ben J. Marais	2
6	Report of three patients with extensive neurocysticercosis in rural southern Tanzania: neurological, serological and neuroradiological findings 2023 ·Journal of Medical Case Reports ·Dominik Stelzle, Charles Makasi, (unknown), (unknown), Veronika Schmidt, Sarah Gabriël, Emmanuel Bottieau, Agnès Fleury, (unknown), Andrea Sylvia Winkler, (unknown), Chiara Trevisan, Inge Van Damme, Pascal Magnussen, Gideon Zulu, Chishala Chabala, (unknown)	1
7	First Pharmacokinetic Data of Tenofovir Alafenamide Fumarate and Tenofovir With Dolutegravir or Boosted Protease Inhibitors in African Children: A Substudy of the CHAPAS-4 Trial 2023 ·Clinical Infectious Diseases ·Hylke Waalewijn, Alexander J. Szubert, Roeland E. Wasmann, Lubbe Wiesner, Chishala Chabala, Mutsa Bwakura‐Dangarembizi, Shafic Makumbi, (unknown), (unknown), Veronica Mulenga, Victor Musiime, (unknown), (unknown), Alasdair Bamford, Katja Doerholt, Paolo Denti, David M. Burger, Diana M. Gibb, Helen McIlleron, Angela Colbers, (unknown)	7
8	Evaluating pediatric tuberculosis dosing guidelines: A model-based individual data pooled analysis 2023 ·PLoS Medicine ·(unknown), Roeland E. Wasmann, Chishala Chabala, Helena Rabie, Janice Lee, Irene Mukui, Anneke C. Hesseling, Heather J. Zar, Rob E. Aarnoutse, Anna Turkova, Diana M. Gibb, Mark F. Cotton, Helen McIlleron, Paolo Denti	4
9	Pharmacokinetic Data of Dolutegravir in Second-line Treatment of Children With Human Immunodeficiency Virus: Results From the CHAPAS4 Trial 2023 ·Clinical Infectious Diseases ·(unknown), Hylke Waalewijn, Alexander J. Szubert, Chishala Chabala, Mutsa Bwakura‐Dangarembizi, Shafic Makumbi, (unknown), (unknown), Veronica Mulenga, Victor Musiime, David M. Burger, Diana M. Gibb, (unknown)	3
10	Brief Report: Suboptimal Lopinavir Exposure in Infants on Rifampicin Treatment Receiving Double-dosed or Semisuperboosted Lopinavir/Ritonavir: Time for a Change 2023 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Tom Jacobs, (unknown), (unknown), (unknown), (unknown), Sara Domínguez‐Rodríguez, Alfredo Tagarro, Kusum Nathoo, (unknown), (unknown), Lola Madrid, Hilda Mujuru, Chishala Chabala, W Chris Buck, Pablo Rojo, David M. Burger, Cinta Moraleda, (unknown)	1
11	Population pharmacokinetics of ethambutol in African children: a pooled analysis 2022 ·Journal of Antimicrobial Chemotherapy ·(unknown), Helen McIlleron, (unknown), Adrie Bekker, Anneke C. Hesseling, Chishala Chabala, Geraint Davies, Heather J. Zar, Helena Rabie, Isabelle Andrieux‐Meyer, Janice Lee, Lubbe Wiesner, Mark F. Cotton, Paolo Denti	3
12	Pharmacokinetics of First-Line Drugs in Children With Tuberculosis, Using World Health Organization–Recommended Weight Band Doses and Formulations 2021 ·Clinical Infectious Diseases ·Chishala Chabala, Anna Turkova, Anneke C. Hesseling, (unknown), (unknown), Monica Kapasa, Megan Palmer, Maxwell Chirehwa, Lubbe Wiesner, Eric Wobudeya, Aarti Kinikar, Vidya Mave, Syed Hissar, Louise Choo, (unknown), Veronica Mulenga, (unknown), Diana M. Gibb, Helen McIlleron	17
13	Trial Design for a Diagnostic Accuracy Study of a Point-of-Care Test for the Detection of Taenia solium Taeniosis and (Neuro)Cysticercosis in Community Settings of Highly Endemic, Resource-Poor Areas in Zambia: Challenges and Rationale 2021 ·Diagnostics ·Inge Van Damme, Chiara Trevisan, Kabemba E. Mwape, Veronika Schmidt, Pascal Magnussen, Gideon Zulu, (unknown), Dominik Stelzle, Emmanuel Bottieau, Emmanuel Abatih, Isaac Phiri, Maria Vang Johansen, Chishala Chabala, Andrea Sylvia Winkler, Pierre Dorny, Sarah Gabriël	9
14	Impact of systematic early tuberculosis detection using Xpert MTB/RIF Ultra in children with severe pneumonia in high tuberculosis burden countries (TB-Speed pneumonia): a stepped wedge cluster randomized trial 2021 ·BMC Pediatrics ·Aurélia Vessière, (unknown), Delphine Gabillard, (unknown), Laurence Borand, Chishala Chabala, Celso Khosa, (unknown), Raoul Moh, Veronica Mulenga, (unknown), (unknown), Mao Tan Eang, Christophe Delacourt, James A. Seddon, (unknown), Sylvain Godreuil, Eric Wobudeya, Maryline Bonnet, Olivier Marcy	6
15	Progress on the development of rapid diagnostic tests for foodborne neglected zoonotic helminthiases: A systematic review 2019 ·Acta Tropica ·(unknown), Kabemba E. Mwape, Isaac K. Phiri, Chiara Trevisan, Gideon Zulu, Chishala Chabala, Inge Van Damme, Veronika Schmidt, Pierre Dorny, Sarah Gabriël	18
16	Tuberculosis caseload in children with severe acute malnutrition related with high hospital based mortality in Lusaka, Zambia 2017 ·BMC Research Notes ·(unknown), Chishala Chabala, (unknown), (unknown), Nathan Kapata, Patrick Musonda, Charles Michelo	34
17	Improved Adherence to Antiretroviral Therapy Observed Among HIV-Infected Children Whose Caregivers had Positive Beliefs in Medicine in Sub-Saharan Africa 2016 ·AIDS and Behavior ·George Abongomera, Adrian Cook, Victor Musiime, Chishala Chabala, Mohammed Lamorde, (unknown), Margaret J. Thomason, Veronica Mulenga, Adeodata Kekitiinwa, Robert Colebunders, Cissy Kityo, A. Sarah Walker, Diana M. Gibb	8
18	Abacavir, zidovudine, or stavudine as paediatric tablets for African HIV-infected children (CHAPAS-3): an open-label, parallel-group, randomised controlled trial 2015 ·The Lancet Infectious Diseases ·Veronica Mulenga, Victor Musiime, Adeodata Kekitiinwa, Adrian Cook, George Abongomera, Julia Kenny, Chishala Chabala, Grace Mirembe, (unknown), (unknown), David M. Burger, Helen McIlleron, Nigel Klein, Chifumbe Chintu, Margaret J. Thomason, Cissy Kityo, A. Sarah Walker, Diana M. Gibb	32
19	Prevalence and Risk Factors for Betaherpesvirus DNAemia in Children >3 Weeks and <2 Years of Age Admitted to a Large Referral Hospital in Sub-Saharan Africa 2014 ·Clinical Infectious Diseases ·John Tembo, Mwila Kabwe, Lophina Chilukutu, (unknown), (unknown), Chishala Chabala, Alimuddin Zumla, Matthew Bates	40
20	High Rates of Congenital Cytomegalovirus Infection Linked With Maternal HIV Infection Among Neonatal Admissions at a Large Referral Center in Sub-Saharan Africa 2013 ·Clinical Infectious Diseases ·(unknown), Lophina Chilukutu, John Tembo, Mwila Kabwe, Kunda Musonda, Monica Kapasa, Chishala Chabala, (unknown), Peter Mwaba, Alimuddin Zumla, Matthew Bates	56

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact